The cellular effects of numerous hormones and neurotransmitters, including the vasoactive agents angiotensin II (Angil) and [Args]vasopressin, are mediated in part by protein-serine/threonine kinases activated by increase of cytosolic Ca2+ concentration. In this study, we have tested the ability of Ca2+-mobilizing agents to activate cellular tyrosine kinases.
over control) by immunoprecipitated kinases closely paralleled the time-and dose-dependence of the appearance of tyrosine phosphoproteins in intact cells. This effect of AnglI was mimicked by thapsigargin, a Ca2+-elevating tumor promoter. The ability of Angl, but not epidermal growth factor, to increase tyrosine kinase activity was blocked in cells loaded with the Ca2' chelator bis-(O-aminophenoxy)-ethane-NNN',N'-tetraacetic acid. Dephosphorylation of immunoprecipitated proteins by tyrosine phosphatase treatment was accompanied by a 60-70% loss in in vitro kinase activity, suggesting that the Angl-sensitive kinase(s) are activated by phosphorylation in intact cells. These findings demonstrate a link between two widely occurring signaling pathways, the tyrosine kinases and the Ca2+ secondmessenger system, and suggest the possible involvement of Ca2+-activated tyrosine kinases in the endocrine actions ofAngIl and [Argglvasopressin.
Reversible phosphorylation of proteins on tyrosine residues is a regulatory mechanism frequently associated with cell growth and mitosis. The receptors for several peptide growth factors, including epidermal growth factor (EGF), plateletderived growth factor, and insulin-like growth factor I, as well as the transforming proteins of several oncogenes (e.g., src, abl) contain tyrosine kinase domains essential for growth-promoting activity (1, 2) . In comparison to the receptor kinases, which are known to be activated by ligand binding, the pathways regulating nonreceptor tyrosine kinases are poorly understood. Likewise, the biological function of nonreceptor tyrosine kinases in both proliferating and nonproliferating cells is unclear. However, the abundance of tyrosine kinase activity in terminally differentiated cells such as platelets (3) and neurons (4) has suggested non-growthrelated roles for tyrosine phosphorylation in processes as diverse as secretion and neural plasticity.
Studies in our laboratory have shown that treatment of WB rat liver epithelial cells with angiotensin II (AngII), [Arg8]vasopressin, or epinephrine rapidly increases cellular protein-phosphotyrosine [Tyr(P)] content in a Ca2+-dependent, protein kinase C-independent fashion (5) . These agents are members of a large class of hormones and neurotransmitters that increase cytosolic Ca2+ and diacylglycerol levels by activating receptors linked to phospholipase C via a GTP-binding protein (6) . In turn, cellular effects of such hormones are believed principally to involve serine/ threonine protein kinases, notably the Ca2+/calmodulindependent kinases and protein kinase C. However, our findings have suggested the existence of an additional pathway by which intracellular Ca2+ acts-modulation of the tyrosine-phosphorylation states of specific proteins (5). Although Ca2I-activated tyrosine phosphorylation recently has been reported in several other cell types, including vascular smooth muscle (7), neutrophils (8) , platelets (9, 10) , and hippocampal cells (11) , the mechanism of this response remains to be elucidated. In the present studies, we have examined the hypothesis that mobilization of Ca2+ increases steady-state levels of tyrosine-phosphorylated proteins by activating tyrosine kinases.
EXPERIMENTAL PROCEDURES
Anti-Tyr(P) Immunoprecipitation. Confluent cultures of GN4 cells in 60-mm dishes were washed once with serumfree medium and were stimulated with various agents at 370C for the times indicated. Cells were lysed with ice-cold lysis buffer [20 mM Hepes (pH 7.3) containing 500 mM NaCl, 50 mM NaF, 5 mM EDTA, 1 mM Na3VO4, 1% Triton X-100, 10% (vol/vol) glycerol, and 10 ,ug of phenylmethylsulfonyl fluoride, 20 ,ug of leupeptin, and 100 kallikrein inhibitor units of aprotinin per ml], and lysates were clarified by centrifugation at 14,000 x g for 15 min at 4°C. Tyrosine-phosphorylated proteins were precipitated by incubation with monoclonal anti-Tyr(P) antibody [qualitatively similar results were obtained with antibodies PY20 (1 ug per 500 pg of total protein; ICN) and PT-66 (1 ,ul per 500 ,ug; Sigma)], 5 Pg of rabbit anti-mouse IgG, and 10 .ul of pansorbin (Calbiochem) for 3 hr at 4°C. Immune complexes were collected by centrifugation at 14,000 x g for 3 min at 4°C, were washed once with lysis buffer and twice with 2-fold-concentrated tyrosine kinase assay buffer (100 mM sodium Hepes, pH 7.6/60 mM MgCl2/2 mM MnCl2/0.2 mM Na3VO4/0.2% Nonidet P-40), and then were resuspended with 70 Al of this buffer. In some experiments, an aliquot (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) pul) of the washed immune complex was removed for anti-Tyr(P) immunoblotting after SDS/PAGE on 8% gels as described (12) . Efficient anti-Tyr(P) recovery of tyrosine phosphoproteins and kinase activity required high NaCl concentration (500 mM) in the cell lysis buffer. We postulate that Tyr(P) residues are dissociated from endogenous binding domains [e.g., src-homology domains (13) ] at high ionic strength and thereby are made accessible for immunoprecipitation, since association of several WB cell tyrosine phosphoproteins with phospholipase C-y1 is reversed at high ionic strength (14) .
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Immune Complex Tyrosine Kinase Assay. Routinely, 10-1.l aliquots of immune complex suspension were preincubated for 5 min at 40C with 160 gg of the synthetic tyrosine kinase substrate poly(Glu8OTyr20) (15) or the control substrate poly-(Glu). Reactions (80-pl total reaction volume) were initiated by addition of 5 gM [y-32P]ATP (5 uCi per reaction; 1 Ci = 37 GBq). After 4 min at 25TC, 50 gl of the reaction mix was spotted onto Whatman 3MM paper. The papers were washed with trichloroacetic acid, air-dried, and assayed by liquid scintillation for acid-insoluble 32p (16) . Tyrosine kinase activity was defined as 32p incorporation in cpm occurring in the presence of poly(Glu80Tyr20) minus that occurring in the presence of poly(Glu). This procedure allows estimation of poly(Glu80Tyr20) phosphorylation above the background of endogenous protein phosphorylation. The rates of tyrosine phosphorylation so measured were linear for at least 15 
RESULTS AND DISCUSSION
In a recent report, we showed that AngII treatment of WB rat liver epithelial cells increases the phosphorylation states of several proteins in a Ca2+-dependent fashion (5) . In the present studies, we have evaluated the effects of Ca2+-mobilizing agents on cellular tyrosine kinases, by measuring tyrosine kinase activities in cell-free preparations. In initial experiments, unfractionated lysates from control and AngIItreated cells were assayed by measuring incorporation of 32p into an acid-insoluble synthetic tyrosine kinase substrate, poly(Glu80Tyr20). However, high background activities of serine/threonine kinases toward endogenous lysate proteins prevented reliable assessment of relative tyrosine kinase activities. We have circumvented this problem by preparing anti-Tyr(P) immunoprecipitates from AngIl-treated cells prior to assay with poly(Glu80Tyr20). This procedure was designed to detect activated tyrosine kinases which, if similar to a number of known receptor and nonreceptor tyrosine kinases (1, 2, (19) (20) (21) (22) (23) , autophosphorylate when activated. Anti-Tyr(P) immunoblotting of anti-Tyr(P) immunoprecipitates from control and treated cells revealed that recovery of tyrosine-phosphorylated proteins was specific and efficient: no tyrosine phosphoproteins were precipitated when nonimmune mouse IgG was substituted for monoclonal anti-Tyr(P) (e.g., see Fig. 4 Left) or when specific immunoprecipitation was blocked by 1 mM phenylphosphate, and no Tyr(P)-containing proteins were detectable in supernatants after one round of immunoprecipitation (not shown).
Initially, studies of tyrosine kinase activation were conducted with the WB and GN4 cell lines. The latter was derived previously from WB cells by serial treatment with N-methyl-N'-nitro-N-nitrosoguanidine (24) . GN4 cells exhibited an -3-fold greater AngII-stimulated increase in endogenous protein-tyrosine phosphorylation compared with WB cells, whereas responses to EGF were of similar magnitude in the two lines (Fig. 1 Upper) . EGF treatment of the two cell types stimulated similar (-3-fold) increases in tyrosine kinase activity measured by using anti-Tyr(P) immunoprecipitates of cell lysates (Fig. 1 Lower) . As anticipated, the activity recovered from EGF-treated cells is due in part to the presence of activated EGF receptors, based on the appearance of a 170-kDa tyrosine-phosphorylated species in antiTyr(P) immunoprecipitates that is recognized by anti-EGF receptor antibodies. AngII treatment of both WB and GN4 cells also stimulated increases in immune complex tyrosine kinase activity (Fig. 1 Lower) , with GN4 cells again being more responsive than WB cells (340% vs. 160o of control activity, respectively). These results are consistent with a link between endogenous protein-tyrosine phosphorylation and kinase activation in response to AngII and prompted us to use GN4 cells in subsequent studies.
The effects of AngII treatment on tyrosine kinase activity were rapid (. 15 Fig. 2 ). This increase corresponded temporally to the appearance of endogenous tyrosine-phosphorylated proteins in intact GN4 cells (not shown). Both responses to AngII were dose-dependent, with half-maximal effects occurring at -1 nM. No measurable tyrosine kinase activity was immunoprecipitated in the presence of phenylphosphate or when anti-Tyr(P) antibodies were replaced by nonimmune IgG.
To validate the results obtained with immunoprecipitates, we performed [32P]ATP-autokinase assays using unfractionated cell lysates prepared in kinase assay buffer containing 1% Triton X-100. Anti-Tyr(P) immunoprecipitation of the in vitro phosphorylated lysates, followed by SDS/PAGE and phosphoamino acid analysis, revealed an :2-fold increase in total protein-associated Tyr(32P) content in lysates of AngIItreated cells compared to controls. These results indicate that relative tyrosine kinase activities measured in anti-Tyr(P) immune complexes are representative of those in cell lysates.
AngIl is known to rapidly increase intracellular Ca2+ and diacylglycerol concentrations in target cells (5, (25) (26) (27) . We have shown that Ca2+ mobilization but not protein kinase C activation is necessary for elevation of tyrosine phosphorylation in response to AngIl (5) . To evaluate the role of Ca2+ in AngII-stimulated tyrosine kinase activation, GN4 cells were loaded with the Ca2+ chelator bis-(O-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid (BAPTA) (28) prior to AngII treatment. In BAPTA-loaded cells, the AngIIstimulated increase in cytosolic Ca2+, measured by fura-2 fluorescence, was reduced by >90%o (Fig. 3 Upper). BAPTA pretreatment also completely abolished the AngII-stimulated increase in immune complex tyrosine kinase activity but had little effect on immune complex tyrosine kinase activity from EGF-treated cells (Fig. 3 Lower). This lack of an effect of BAPTA on EGF receptor kinase activity is consonant with the known Ca2+-independence of this enzyme (29) and indicates the absence of toxic or nonspecific effects of BAPTA on GN4 cells in this context. To further evaluate the involvement of Ca2+ in tyrosine kinase activation, GN4 cells were treated with the tumor promoter thapsigargin, which promotes Ca2+ release from endoplasmic reticulum (30) . Treatment with 2 ,uM thapsigargin for 5 min increased immune complex tyrosine kinase activity to 245 ± 38% of vehicle controls (mean ± SEM, n = 5 separate experiments). In contrast, treatment with the protein kinase C activator phorbol myristate acetate at 300 nM for 10 min had no significant effect on recovery of tyrosine kinase activity.
The successful recovery of tyrosine kinase activity from AngII-treated cells by anti-Tyr(P) immunoprecipitation suggests that this activity may reside in one or more of the tyrosine-phosphorylated species detected by immunoblotting (Fig. 1) . To investigate the possible presence of autophosphorylating kinases, anti-Tyr(P) immune complexes were lated rat liver EGF receptor was used as a substrate. Furthermore, there was no detectable loss of Tyr(P) from immunoprecipitated proteins when either immune complexes or eluted phosphoproteins were incubated for up to 30 min in the presence of all kinase assay components except ATP. Therefore, it is unlikely that decreased recovery of phosphatase activity rather than increased kinase activity can account for the effects of AngII treatment on phosphorylation rates in the immune complex assay.
Secondly, it might be argued that the presence of precipitating antibodies in the immune complex assay could artifactually alter tyrosine kinase activities. To test this possibility, Tyr(P) proteins were specifically eluted from immune complexes prior to kinase assay. Washed anti-Tyr(P) immunoprecipitates from control and AngII-treated GN4 cells were resuspended in 2-fold concentrated assay buffer containing 1 mM p-nitrophenyl phosphate. After 30 min at 4°C, eluted proteins were separated from the immune complex by centrifugation for 5 min at 14,000 x g and 4°C. p-Nitrophenyl phosphate eluted >95% of the detectable Tyr(P) proteins from anti-Tyr(P) antibodies. There was no detectable change in tyrosine kinase activity in eluates compared with noneluted immune complexes assayed either by autophosphorylation or poly(Glu81'yr20) phosphorylation (not shown), indicating that the precipitating antibodies do not influence the activity of the recovered kinases.
Finally, the possibility exists that increased recovery of tyrosine kinase activity merely reflects an increase in the pool of phosphorylated tyrosine kinase molecules by a process that is not a consequence of kinase activation. To assess the relationship between the phosphorylation state of recovered kinases and their activities, Tyr(P) proteins eluted from immune complexes were dephosphorylated by treatment with recombinant human T-cell tyrosine phosphatase (37-kDa form) (31) . Tyrosine phosphatase treatment removed virtually all detectable tyrosine phosphate from eluted proteins (Fig. 5 Left). This dephosphorylation was accompanied by a 60-70%o loss in the kinase activity measured subsequently with poly(Glu8OTyr20) in the presence of vanadate (Fig. 5 Right). The ability of vanadate to inhibit the T-cell phosphatase was confirmed by the complete blockade of protein dephosphorylation when phosphatase incubations contained vanadate ( Fig. 5 Left) ; inhibition of dephosphorylation was accompanied by retention of kinase activity (Fig.  5 Right). Therefore, we conclude that the loss of kinase activity stems from dephosphorylation of immunoprecipi- Loss of tyrosine kinase activity after tyrosine dephosphorylation. Anti-Tyr(P) immunoprecipitates from control and AngII-treated GN4 cells were washed twice with 25 mM imidazole (pH 7.2) and eluted from anti-Tyr(P) by incubation with this buffer containing 0.05% Triton X-100, 0.1% 2-mercaptoethanol, and 1 mM p-nitrophenyl phosphate. Eluted proteins were incubated with 1 mM sodium orthovanadate (lanes Van.) , recombinant T-cell tyrosine phosphatase (lanes PTPase; -1 ng/pg of total cell protein), or vanadate plus phosphatase for 3 min at 250C. Vanadate (1 mM) was then added to phosphatase-only samples, and aliquots of all samples were subjected to anti-Tyr(P) immunoblotting (Left) or in vitro kinase assay with poly(GluwJTyr2O) (Right). of t tated proteins rather than from residual activity of T-cell phosphatase toward poly(Glu8Tyr20) or from other contaminating hydrolases. This finding indicates that the tyrosine phosphorylation of tyrosine kinases (or persistently associated regulatory proteins) recovered from AngII-treated cells both reflects and dictates increased kinase activity. Furthermore, these results validate our rationale for seeking evidence of kinase activation that occurred in intact cells by examining anti-Tyr(P) immunoprecipitates.
The sensitivity of AngII-stimulated tyrosine kinase activities to tyrosine dephosphorylation strongly suggests that phosphorylation of these kinases is a major factor in their mechanism of activation. It remains to be established whether this increased kinase phosphorylation is due to autophosphorylation or activation of an intermediating kinase. In either event, these putative enzymes could be directly regulated in a positive manner by increased intracellular Ca2+, as suggested for a reported Ca2+/calmodulinactivated tyrosine kinase (32) or a soybean serine/threonine kinase that contains a Ca2+-binding domain (33) . Alternatively, modulation oftyrosine phosphatase activity may be an event more proximal to AngII-stimulated Ca2+ mobilization. Thus, Ca2+ might maintain one or more tyrosine kinases in an activated (i.e., tyrosine-phosphorylated) state by inhibiting their dephosphorylation. Such a mechanism would require the presence of a basal level of phosphorylating (i.e., kinaseactivating) activity in untreated cells, a criterion that is satisfied by the recovery of measurable phosphatasesensitive tyrosine kinase activity from control cells (Fig. 5) .
A tyrosine phosphatase that is inhibited by Ca2+ has been isolated from bovine brain (34) , and Ca2+-mediated inhibition of the leukocyte tyrosine phosphatase CD45 has been reported (35) , but the involvement of an analogous mechanism in WB or GN4 cells is untested.
The identity of the kinase(s) involved in AngII-stimulated increases in tyrosine phosphorylation remains unknown. We must consider as candidates known tyrosine kinases, such as the insulin receptor (21, 22) and members of the src family (23, 36, 37) , whose activity appears to be regulated positively by autophosphorylation. We have found that immunoprecipitation with antibodies recognizing the common C-terminal peptide of src-related kinases did not decrease AngIIstimulated tyrosine kinase activity subsequently recovered with anti-Tyr(P) (unpublished data), suggesting that the Ang-II-responsive enzymes are not members of this kinase family. In addition, preliminary subcellular fractionation studies indicate that at least part of the AngII-stimulated activity is cytosolic, suggesting that this activity cannot wholly be attributed to transmembrane kinases such as the insulin receptor. Ongoing studies seek to identify the AngIIresponsive kinases and to determine whether their mode of activation is common to many cell types. Given the widespread occurrence of receptor-mediated Ca2+ mobilization, we anticipate that Ca2+-dependent tyrosine kinase activation may prove to be of fundamental interest, and elucidation of its mechanism may provide new insights into both the acute and growth-regulating actions of Ca2+-mobilizing hormones and neurotransmitters.
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